对肺高血压的正念冥想计划开发:技术辅助的补充性健康干预措施的可接受性和可行性,用于症状自我管理
Tania T Von Visger1, Yu-Ping Chang2
1Assistant Professor, The Medical University of South Carolina, College of Nursing, Charleston, SC, USA.
肺高血压正念冥想 (MMPH) 计划在试点研究中显示出适度的可接受性和可行性. 参与者报告了感知到的好处,改善了PH症状,以及日常实践的整合.
科学领域:
- 行为健康干预 行为健康干预
- 数字健康数字健康
- 肺高血压管理 肺高血压管理
背景情况:
- 患有肺高血压 (PH) 的成年人经历了显著的症状负担和生活质量的降低.
- 基于正念的干预措施 (MBI) 证明了对慢性疾病 (包括PH) 的临床益处.
- 基于网络的肺高血压正念冥想 (MMPH) 计划的试点测试表明,抑郁症,症状和生活质量有所改善.
研究的目的:
- 从数量和质量上评估MMPH计划的可接受性和可行性.
- 评估参与者对各种MMPH组件的坚持和参与.
- 确定与MMPH计划参与者的经验相关的关键主题.
主要方法:
- 描述性统计分析了15名参与者中Zoom,视频和应用程序使用的坚持和完成率.
- 在MMPH应用程序的每日反思期刊上进行了定性主题分析.
- 系统可用性量表 (SUS) 衡量了程序的可接受性.
主要成果:
- 对Zoom会议 (93%) 和视频活动 (80%) 的高度坚持.
- 适度的应用使用 (53%使用,40%>2周).
- 出现在四个突出的主题:感知好处,日常练习,意识/接受和症状改善. 苏斯得分为81.47 (中等可接受性).
结论:
- 对像MMPH这样的复杂行为干预来说,可行性和可接受性评估至关重要.
- 这些发现支持了对指导计划修改的综合方法的需求.
- 这项研究为MMPH计划的未来现实世界实施科学测试提供了基础.
更多相关视频
10:45A Community-based Stress Management Program: Using Wearable Devices to Assess Whole Body Physiological Responses in Non-laboratory Settings
Published on: January 22, 2018
08:08Using Wavelet Entropy to Demonstrate how Mindfulness Practice Increases Coordination between Irregular Cerebral and Cardiac Activities
Published on: May 10, 2017
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Stress Prevention and Stress Management Techniques III
The Role of Exercise in Stress Management
Regular physical activity is essential for reducing stress and promoting cardiovascular health. Exercise strengthens the heart, enhances blood flow, keeps blood vessels flexible, and helps lower blood pressure, all of which reduce the body's stress response. Research shows that adults who exercise regularly have nearly half the...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
